Latest news

• Malaria vaccine is first to provide 'sustained protection'

  The PfSPZ vaccine had previously been shown to provide a short-term immunological response targeted at the malaria parasite, but in the latest trial was shown to provide protection against infection ... Sanaria chief executive Stephen Hoffmann said that

• Scientists finds new drug target for malaria

  In August NIV researchers said they had achieved "unprecedented" results in a small study of a weakened, live Plasmodium falciparum vaccine called PfSPZ.

• GSK hoping to file malaria vaccine next year

  In the summer, researcher at the US National Institutes of Health (NIH) reported encouraging early clinical of another candidate called PfSPZ - in development at small US biotech Sanaria - which provided complete

• Malaria vaccine gives "unprecedented" results

  At the highest dose tested, vaccination with the PfSPZ shot provided complete protection against malaria in six patients. ... The researchers found that participants who received a higher total dosage of PfSPZ generated more antibodies against malaria